Shares of bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $116.05 and traded as low as $110.57. bioMérieux shares last traded at $110.57, with a volume of 9 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, UBS Group raised bioMérieux to a “strong-buy” rating in a research note on Thursday, August 22nd.
View Our Latest Stock Analysis on BMXMF
bioMérieux Trading Down 3.8 %
About bioMérieux
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Read More
- Five stocks we like better than bioMérieux
- P/E Ratio Calculation: How to Assess Stocks
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- What is the S&P 500 and How It is Distinct from Other Indexes
- Breakout Alert: Qualcomm Just Hit The Rally Button
- How to Calculate Stock Profit
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
